RESEARCH TRIANGLE PARK – Morrisville-based Locus Biosciences, a developer of precision antibacterial therapies, will conduct the world’s first clinical trial of a recombinant bacteriophage therapy, a ...
A filing with the U.S. Securities and Exchange Commission gives new insights into Research Triangle Park-based Locus Biosciences' deal to buy California competitor EpiBiome. The terms of the deal were ...
For generations, antibiotics have been a boon to humanity, saving untold numbers of people from deadly infections and bacteria. But as those antibiotics have been overused across the world — both in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback